Israeli researchers on Monday said that they discovered a link between Pfizer’s COVID-19 vaccine and a rare blood disease called thrombotic thrombocytopenic purpura (TTP).
Scientists with the Institute of Hematology at Shamir Medical Center said they began researching the possible link after reports of a sudden increase in TTP across Israel.